BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McCaughan GW, Zekry A. Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection. Transpl Infect Dis. 2000;2:166-185. [PMID: 11429029 DOI: 10.1034/j.1399-3062.2000.020403.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Shackel N, Patel K, Mchutchison J. Diagnosis, Management and Disease Mechanisms of Hepatitis in the Era of Genomic Medicine. Genomic and Personalized Medicine. Elsevier; 2009. pp. 1375-89. [DOI: 10.1016/b978-0-12-369420-1.00112-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Kaplan DE. Immunopathogenesis of Hepatitis C Virus Infection. Gastroenterol Clin North Am 2015;44:735-60. [PMID: 26600217 DOI: 10.1016/j.gtc.2015.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
3 Bobak DA, Yadavalli G. Update on the management of hepatitis C in liver transplant recipients. Curr Infect Dis Rep 2002;4:105-11. [DOI: 10.1007/s11908-002-0049-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Wodarz D. Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses. J Gen Virol. 2003;84:1743-1750. [PMID: 12810868 DOI: 10.1099/vir.0.19118-0] [Cited by in Crossref: 109] [Cited by in F6Publishing: 49] [Article Influence: 5.7] [Reference Citation Analysis]
5 Rodriguez-Luna H, Douglas DD. Natural history of hepatitis C following liver transplantation. Curr Opin Infect Dis. 2004;17:363-371. [PMID: 15241083 DOI: 10.1097/01.qco.0000136934.06039.01] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
6 Della Bella S, Crosignani A, Riva A, Presicce P, Benetti A, Longhi R, Podda M, Villa ML. Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection. Immunology. 2007;121:283-292. [PMID: 17462079 DOI: 10.1111/j.1365-2567.2007.02577.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
7 McCaughan GW, Zekry A. Pathogenesis of hepatitis C virus recurrence in the liver allograft. Liver Transpl 2002;8:S7-S13. [PMID: 12362292 DOI: 10.1053/jlts.2002.35856] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
8 Vukotic R, Vitale G, D’Errico-Grigioni A, Muratori L, Andreone P. De novo autoimmune hepatitis in liver transplant: State-of-the-art review. World J Gastroenterol 2016; 22(10): 2906-2914 [PMID: 26973387 DOI: 10.3748/wjg.v22.i10.2906] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
9 Rodriguez-luna H, Vargas HE. Management of hepatitis C virus infection in the setting of liver transplantation. Liver Transpl 2005;11:479-89. [DOI: 10.1002/lt.20424] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
10 Cacoub P, Benhamou Y. Place des interférons dans le traitement des infections par les virusde l'hépatite B et de l'hépatite C. La Revue de Médecine Interne 2002;23:459S-74S. [DOI: 10.1016/s0248-8663(02)00660-4] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
11 McCaughan GW, Zekry A. Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation. Liver Transpl. 2003;9:S21-S27. [PMID: 14586891 DOI: 10.1053/jlts.2003.50269] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
12 Rubin RH. Infection in the Organ Transplant Recipient. In: Rubin RH, Young LS, Van Furth R, editors. Clinical Approach to Infection in the Compromised Host. Boston: Springer US; 2002. pp. 573-679. [DOI: 10.1007/0-306-47527-8_17] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
13 Rubin R. Control of hepatitis in the transplant patient: a journey begun - but not there yet: Editorial. Transplant Infectious Disease 2000;2:151-2. [DOI: 10.1111/j.1399-3062.2000.20401.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Humar A, Kumar D, Raboud J, Caliendo AM, Moussa G, Levy G, Mazzulli T. Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation. Am J Transplant. 2002;2:461-466. [PMID: 12123213 DOI: 10.1034/j.1600-6143.2002.20511.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 4.1] [Reference Citation Analysis]
15 Kimball P, Verbeke S, Shiffman M. HCV Core Protein Augments Cyclosporine Immunosuppression. Transplantation Proceedings 2005;37:652-3. [DOI: 10.1016/j.transproceed.2004.12.293] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
16 Maluf DG, Archer KJ, Villamil F, Stravitz RT, Mas V. Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression. Expert Review of Gastroenterology & Hepatology 2014;4:445-58. [DOI: 10.1586/egh.10.39] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
17 Peterson JR, Hsu FC, Simkin PA, Wener MH. Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis. 2003;62:1078-1082. [PMID: 14583571 DOI: 10.1136/ard.62.11.1078] [Cited by in Crossref: 151] [Cited by in F6Publishing: 136] [Article Influence: 7.9] [Reference Citation Analysis]
18 Shackel NA, Seth D, Haber PS, Gorrell MD, McCaughan GW. The hepatic transcriptome in human liver disease. Comp Hepatol 2006;5:6. [PMID: 17090326 DOI: 10.1186/1476-5926-5-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
19 Dall’Agata M, Gramenzi A, Biselli M, Bernardi M. Hepatitis C virus reinfection after liver transplantation: Is there a role for direct antiviral agents? World J Gastroenterol 2014; 20(28): 9253-9260 [PMID: 25071318 DOI: 10.3748/wjg.v20.i28.9253] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Righi E, Londero A, Carnelutti A, Baccarani U, Bassetti M. Impact of new treatment options for hepatitis C virus infection in liver transplantation. World J Gastroenterol 2015; 21(38): 10760-10775 [PMID: 26478668 DOI: 10.3748/wjg.v21.i38.10760] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
21 Chuang E, Del Vecchio A, Smolinski S, Song XY, Sarisky RT. Biomedicines to reduce inflammation but not viral load in chronic HCV--what’s the sense? Trends Biotechnol. 2004;22:517-523. [PMID: 15450745 DOI: 10.1016/j.tibtech.2004.08.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
22 Gaglio PJ, Malireddy S, Levitt BS, Lapointe-Rudow D, Lefkowitch J, Kinkhabwala M, Russo MW, Emond JC, Brown RS. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl. 2003;9:1028-1035. [PMID: 14526396 DOI: 10.1053/jlts.2003.50211] [Cited by in Crossref: 104] [Cited by in F6Publishing: 84] [Article Influence: 5.8] [Reference Citation Analysis]
23 Akalin E, Murphy B, Sehgal V, Ames S, Daly L, Bromberg JS. Rapid steroid withdrawal in hepatitis C virus-positive kidney transplant recipients. Clin Transplant. 2004;18:384-389. [PMID: 15233814 DOI: 10.1111/j.1399-0012.2004.00177.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
24 Radecke K, Frühauf NR, Miller M, Ross B, Köditz R, Malagó M, Broelsch CE, Gerken G, Treichel U. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis: Liver transplantation and HIV infection. Liver International 2005;25:101-8. [DOI: 10.1111/j.1478-3231.2005.01031.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
25 Neuman MG, Benhamou JP, Marcellin P, Valla D, Malkiewicz IM, Katz GG, Trepo C, Bourliere M, Cameron RG, Cohen L. Cytokine--chemokine and apoptotic signatures in patients with hepatitis C. Transl Res. 2007;149:126-136. [PMID: 17320798 DOI: 10.1016/j.trsl.2006.11.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]